An open-label, uncontrolled, single-arm pilot study to evaluate vascular interventional therapy mediated CEA-targeted chimeric antigen receptor T cells in advanced colorectal cancer
An open-label, uncontrolled, single-arm pilot study to evaluate vascular interventional therapy mediated GPC3-targeted chimeric antigen receptor T cells in advanced hepatocellular carcinoma
A study to assess mesothelin-targeted immunotherapy T cells in patients with mesothelin+ malignant pleural mesothelioma and pancreatic carcinoma.
100 Clinical Results associated with Shanghai Genechem Co., Ltd.
0 Patents (Medical) associated with Shanghai Genechem Co., Ltd.
100 Deals associated with Shanghai Genechem Co., Ltd.
100 Translational Medicine associated with Shanghai Genechem Co., Ltd.